Literature DB >> 20035383

In vivo neuroprotective effects of peripheral kynurenine on acute neurotoxicity induced by glutamate in rat cerebral cortex.

Alok Kumar1, G Nagesh Babu.   

Abstract

N-methyl-D-aspartate (NMDA) receptors play a crucial role in Glutamate (L-Glu) neurotoxicity. To evaluate the effects of astrocyte-derived tryptophan metabolite kynurenic acid (KYNA), on L-Glu neurotoxicity, adult male rats were pretreated with Kynurenine (KYN) which is a precursor of KYNA, at a dose of 30 mg or 300 mg/kg bw i.p., 2 h before stereotactic L-Glu bolus (1 micromole/1 microl) administration in cerebral cortex. Results showed that acute L-Glu increased reactive oxygen species, rate of lipid peroxidation, calcium, nitric oxide and neuroinflammatory markers viz. TNF-alpha, IFN-gamma levels and decreased key antioxidant parameters such as SOD, catalase, total glutathione and glutathione reductase along with mitochondrial membrane potential. While peripheral loading of 30 mg/kg dose of KYN had no protective effects on L-Glu induced neurotoxicity, 300 mg/kg dose prevented the above toxic effects following intracortical L-Glu. KYN apparently crossed blood brain barrier to elevate astrocytic-KYNA level, which seems to protect neurons through several interactive mechanisms.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035383     DOI: 10.1007/s11064-009-0114-6

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  23 in total

1.  Neuroprotection achieved in the ischaemic rat cortex with L-kynurenine sulphate.

Authors:  Hermina Robotka; Katalin Sas; Márta Agoston; Eva Rózsa; Gábor Szénási; Gábor Gigler; László Vécsei; József Toldi
Journal:  Life Sci       Date:  2008-03-02       Impact factor: 5.037

2.  Enzymatic assay for glutathione.

Authors:  J E Brehe; H B Burch
Journal:  Anal Biochem       Date:  1976-07       Impact factor: 3.365

Review 3.  Endogenous kynurenines as targets for drug discovery and development.

Authors:  Trevor W Stone; L Gail Darlington
Journal:  Nat Rev Drug Discov       Date:  2002-08       Impact factor: 84.694

4.  Kynurenic acid has a dual action on AMPA receptor responses.

Authors:  Christina Prescott; Autumn M Weeks; Kevin J Staley; Kathryn M Partin
Journal:  Neurosci Lett       Date:  2006-04-27       Impact factor: 3.046

5.  Catalase in vitro.

Authors:  H Aebi
Journal:  Methods Enzymol       Date:  1984       Impact factor: 1.600

6.  Reduction in oxidative stress and cell death explains hypothyroidism induced neuroprotection subsequent to ischemia/reperfusion insult.

Authors:  Leena Rastogi; Madan M Godbole; Madhur Ray; Priyanka Rathore; Priyanka Rathore; Sunil Pradhan; Sushil K Gupta; Chandra M Pandey
Journal:  Exp Neurol       Date:  2006-04-17       Impact factor: 5.330

Review 7.  The role of kynurenines in disorders of the central nervous system: possibilities for neuroprotection.

Authors:  Eniko Vamos; Arpad Pardutz; Peter Klivenyi; Jozsef Toldi; Laszlo Vecsei
Journal:  J Neurol Sci       Date:  2009-03-05       Impact factor: 3.181

8.  Blood-brain barrier transport of kynurenines: implications for brain synthesis and metabolism.

Authors:  S Fukui; R Schwarcz; S I Rapoport; Y Takada; Q R Smith
Journal:  J Neurochem       Date:  1991-06       Impact factor: 5.372

9.  Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity.

Authors:  B Poeggeler; A Rassoulpour; H-Q Wu; P Guidetti; R C Roberts; R Schwarcz
Journal:  Neuroscience       Date:  2007-07-16       Impact factor: 3.590

10.  Elevated inflammatory markers in a group of amyotrophic lateral sclerosis patients from northern India.

Authors:  G Nagesh Babu; Alok Kumar; Ramesh Chandra; S K Puri; Jayantee Kalita; U K Misra
Journal:  Neurochem Res       Date:  2008-02-02       Impact factor: 3.996

View more
  7 in total

Review 1.  All roads lead to Rome - a review of the potential mechanisms by which exerkines exhibit neuroprotective effects in Alzheimer's disease.

Authors:  Yi-Yao Liang; Li-Dan Zhang; Xi Luo; Li-Li Wu; Zhao-Wei Chen; Guang-Hao Wei; Kai-Qing Zhang; Ze-An Du; Ren-Zhi Li; Kwok-Fai So; Ang Li
Journal:  Neural Regen Res       Date:  2022-06       Impact factor: 5.135

Review 2.  Is L-Glutamate Toxic to Neurons and Thereby Contributes to Neuronal Loss and Neurodegeneration? A Systematic Review.

Authors:  Maryam N Al-Nasser; Ian R Mellor; Wayne G Carter
Journal:  Brain Sci       Date:  2022-04-29

3.  Attention-deficit hyperactivity disorder (ADHD) and glial integrity: an exploration of associations of cytokines and kynurenine metabolites with symptoms and attention.

Authors:  Robert D Oades; Aye-Mu Myint; Maria R Dauvermann; Benno G Schimmelmann; Markus J Schwarz
Journal:  Behav Brain Funct       Date:  2010-06-09       Impact factor: 3.759

4.  Carnosine attenuates early brain injury through its antioxidative and anti-apoptotic effects in a rat experimental subarachnoid hemorrhage model.

Authors:  Zong-yong Zhang; Bao-liang Sun; Ming-feng Yang; Da-wei Li; Jie Fang; Shuai Zhang
Journal:  Cell Mol Neurobiol       Date:  2014-09-02       Impact factor: 5.046

5.  Moderate- and Low-Dose of Atorvastatin Alleviate Cognition Impairment Induced by High-Fat Diet via Sirt1 Activation.

Authors:  Hong Liu; Jie Yang; Kai Wang; Tengfei Niu; Dongya Huang
Journal:  Neurochem Res       Date:  2019-02-28       Impact factor: 3.996

Review 6.  Kynurenines, neurodegeneration and Alzheimer's disease.

Authors:  Zsigmond Tamas Kincses; József Toldi; László Vécsei
Journal:  J Cell Mol Med       Date:  2010-07-12       Impact factor: 5.310

7.  Exploitation of the IDO Pathway in the Therapy of Rheumatoid Arthritis.

Authors:  Richard O Williams
Journal:  Int J Tryptophan Res       Date:  2013-07-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.